314 related articles for article (PubMed ID: 33544031)
1. The Low-Alkalinity Polymyxin Derivative, AL-6, Shows High Activity Against Multidrug-Resistant
Chen DJ; Cui AL; Chen JR; Yang P; Jin J; Shao L; Li ZR
Microb Drug Resist; 2021 Jul; 27(7):933-941. PubMed ID: 33544031
[TBL] [Abstract][Full Text] [Related]
2. Origanum vulgare essential oil: antibacterial activities and synergistic effect with polymyxin B against multidrug-resistant Acinetobacter baumannii.
Amaral SC; Pruski BB; de Freitas SB; Allend SO; Ferreira MRA; Moreira C; Pereira DIB; Junior ASV; Hartwig DD
Mol Biol Rep; 2020 Dec; 47(12):9615-9625. PubMed ID: 33190200
[TBL] [Abstract][Full Text] [Related]
3. Model-informed dose optimisation of polymyxin-rifampicin combination therapy against multidrug-resistant Acinetobacter baumannii.
Zhao J; Zhu Y; Han ML; Lu J; Yu HH; Wickremasinghe H; Zhou QT; Bergen P; Rao G; Velkov T; Lin YW; Li J
Int J Antimicrob Agents; 2023 Sep; 62(3):106902. PubMed ID: 37380093
[TBL] [Abstract][Full Text] [Related]
4. Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumannii.
Zhao J; Han ML; Zhu Y; Lin YW; Wang YW; Lu J; Hu Y; Tony Zhou Q; Velkov T; Li J
Biochem Pharmacol; 2021 Feb; 184():114400. PubMed ID: 33387481
[TBL] [Abstract][Full Text] [Related]
5. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
Thomas VM; Brown RM; Ashcraft DS; Pankey GA
Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
[TBL] [Abstract][Full Text] [Related]
7. Performances of the Rapid Polymyxin
Lescat M; Poirel L; Jayol A; Nordmann P
Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
[No Abstract] [Full Text] [Related]
8. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
9. Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance.
Cheah SE; Li J; Tsuji BT; Forrest A; Bulitta JB; Nation RL
Antimicrob Agents Chemother; 2016 Jul; 60(7):3921-33. PubMed ID: 27067324
[TBL] [Abstract][Full Text] [Related]
10.
Chen H; Li H; Liu Z; Li J
Microb Drug Resist; 2020 Sep; 26(9):1108-1119. PubMed ID: 32349617
[TBL] [Abstract][Full Text] [Related]
11. Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates.
Girardello R; Visconde M; Cayô R; Figueiredo RC; Mori MA; Lincopan N; Gales AC
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):37-44. PubMed ID: 27776788
[TBL] [Abstract][Full Text] [Related]
12. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Doymaz MZ; Karaaslan E
Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
[No Abstract] [Full Text] [Related]
14. Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.
Mohd Sazlly Lim S; Naicker S; Ayfan AK; Zowawi H; Roberts JA; Sime FB
Int J Antimicrob Agents; 2020 Oct; 56(4):106115. PubMed ID: 32721600
[TBL] [Abstract][Full Text] [Related]
15. [Application progress of polymyxin in bloodstream infection of drug-resistant Acinetobacter baumannii].
Zhang S; Sun L; Sun L; Yang Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1401-1404. PubMed ID: 34980319
[TBL] [Abstract][Full Text] [Related]
16. Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
Shukla M; Soni I; Matsuyama K; Tran T; Tanga M; Gong L; Chopra S
Int J Antimicrob Agents; 2018 Jul; 52(1):22-27. PubMed ID: 29501820
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
Akin FE; Bayram A; Balci I
Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
[TBL] [Abstract][Full Text] [Related]
19. Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.
Maifiah MH; Cheah SE; Johnson MD; Han ML; Boyce JD; Thamlikitkul V; Forrest A; Kaye KS; Hertzog P; Purcell AW; Song J; Velkov T; Creek DJ; Li J
Sci Rep; 2016 Feb; 6():22287. PubMed ID: 26924392
[TBL] [Abstract][Full Text] [Related]
20.
Duncan LR; Wang W; Sader HS
Antimicrob Agents Chemother; 2022 May; 66(5):e0013922. PubMed ID: 35475635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]